These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 4208098

  • 1. [Clinical experiences with SPN 40150 in hyperlipidemia and arteriosclerotic circulatory disturbances (author's transl)].
    Schimert G.
    MMW Munch Med Wochenschr; 1974 Feb 22; 116(8):389-92. PubMed ID: 4208098
    [No Abstract] [Full Text] [Related]

  • 2. Comparative investigations on the effect of nicotinic acid alone and in association with a synthetic, heparin-like sulfated polyanion on fibrinolysis, platelet aggregation and lipidic fractions.
    Turazza G, Spreafico PL, Frandoli G.
    Arzneimittelforschung; 1973 May 22; 23(5):654-7. PubMed ID: 4575777
    [No Abstract] [Full Text] [Related]

  • 3. [A double-blind cross-over trial of a new hypolipidaemic drug (author's transl)].
    Proto C, Quadri A, Ratti S, Levi GF, Prandini BD.
    G Ital Cardiol; 1978 May 22; 8(7):743-51. PubMed ID: 355033
    [Abstract] [Full Text] [Related]

  • 4. Diet and drug treatment of hyperlipidemia and atherosclerosis.
    Kuo PT.
    Ann Clin Lab Sci (1971); 1972 May 22; 2(4):322-4. PubMed ID: 4342101
    [No Abstract] [Full Text] [Related]

  • 5. Effect of nicotinic acid on plasma lipids in patients with hyperlipoproteinemia during the first week of treatment.
    Carlson LA, Orö L, Ostman J.
    J Atheroscler Res; 1968 May 22; 8(4):667-77. PubMed ID: 5679950
    [No Abstract] [Full Text] [Related]

  • 6. [The problem of an antilipemic synergism between the action of nicotinic acid and the sulphated polyanion SP54 (author's transl)].
    Levy H.
    Med Klin; 1974 Sep 06; 69(36):1441-7. PubMed ID: 4280008
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Clinical valuation of "Plasmaclar", a new drug for the treatment of hyperlipaemias (author's transl)].
    Ferrer García JL.
    Folia Clin Int (Barc); 1973 Nov 06; 23(11):782-94. PubMed ID: 4773216
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [New drug combination for medical management of hyperlipemia: clinical study].
    Fischer M, Falkensammer C.
    Int J Clin Pharmacol Biopharm; 1977 Dec 06; 15(12):585-9. PubMed ID: 340391
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Study of serum lipid fractions as related to blood coagulation, fibrinolysis and platelet aggregation in cholesterol fed rabbits and in arteriosclerotic patients given clofibrate.
    Baldoni E, Egge H, Cuttin S, Murawski U, Gibelli A, Giarola P.
    Farmaco Sci; 1973 Sep 06; 28(9):713-21. PubMed ID: 4749857
    [No Abstract] [Full Text] [Related]

  • 16. [Long-term effect of alufibrate in various types of hyperlipidaemia (author's transl)].
    Stähelin HB, Hartmann G.
    Dtsch Med Wochenschr; 1974 Jun 28; 99(26):1392-4 passim. PubMed ID: 4601124
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Effect of tocopherol nicotinate on serum lipids].
    Aigner O, Schlick W.
    Int J Clin Pharmacol; 1974 Sep 28; 10(2):124-8. PubMed ID: 4448553
    [No Abstract] [Full Text] [Related]

  • 20. [Therapeutic possibilities in blood circulatory and lipid metabolism disorders].
    Schneider H.
    Z Allgemeinmed; 1971 Dec 31; 47(36):1916-8. PubMed ID: 5003958
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.